IL83821A0 - Azaindole and indolizine derivatives,their production and pharmaceutical compositions containing them - Google Patents

Azaindole and indolizine derivatives,their production and pharmaceutical compositions containing them

Info

Publication number
IL83821A0
IL83821A0 IL83821A IL8382187A IL83821A0 IL 83821 A0 IL83821 A0 IL 83821A0 IL 83821 A IL83821 A IL 83821A IL 8382187 A IL8382187 A IL 8382187A IL 83821 A0 IL83821 A0 IL 83821A0
Authority
IL
Israel
Prior art keywords
azaindole
production
pharmaceutical compositions
compositions containing
indolizine derivatives
Prior art date
Application number
IL83821A
Other languages
English (en)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/945,750 external-priority patent/US4751235A/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL83821A0 publication Critical patent/IL83821A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL83821A 1986-09-10 1987-09-08 Azaindole and indolizine derivatives,their production and pharmaceutical compositions containing them IL83821A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90589786A 1986-09-10 1986-09-10
US06/945,750 US4751235A (en) 1986-12-23 1986-12-23 Anti-atherosclerotic indolizine derivatives

Publications (1)

Publication Number Publication Date
IL83821A0 true IL83821A0 (en) 1988-02-29

Family

ID=27129444

Family Applications (1)

Application Number Title Priority Date Filing Date
IL83821A IL83821A0 (en) 1986-09-10 1987-09-08 Azaindole and indolizine derivatives,their production and pharmaceutical compositions containing them

Country Status (12)

Country Link
EP (1) EP0265640A3 (xx)
JP (1) JPH01500834A (xx)
KR (1) KR880701719A (xx)
AU (1) AU606621B2 (xx)
DK (1) DK254488A (xx)
FI (1) FI882160A0 (xx)
HU (1) HU200769B (xx)
IL (1) IL83821A0 (xx)
NZ (1) NZ221717A (xx)
PL (1) PL267646A1 (xx)
PT (1) PT85662B (xx)
WO (1) WO1988001997A2 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0352575A3 (de) * 1988-07-28 1991-08-21 Bayer Ag Substituierte anellierte Pyrrole
IL91941A (en) * 1988-10-13 1994-10-21 Sandoz Ag Preparation of 6-Anoic and 7-Metanoic Fatty Acids and Their Substances and Intermediate Compounds and Acid 7-] 3-) 4-Fluorophenyl (-1-) 1- Methylethyl (a)
JPH04270285A (ja) * 1988-11-14 1992-09-25 Nissan Chem Ind Ltd ピラゾロピリミジン系メバロノラクトン類
US5025000A (en) * 1990-03-02 1991-06-18 E. R. Squibb & Sons, Inc. Phosphorus-containing HMG-CoA reductase inhibitor compounds
US5124453A (en) * 1990-03-02 1992-06-23 E. R. Squibb & Sons, Inc. Process for preparing certain 5,6,7,8-tetrahydroindolizinyl (ethyl or ethynyl)-hydroxy or methoxy-phosphinyl-3-hydroxy-butanoates and derivatives thereof
WO1992019239A1 (en) * 1991-05-01 1992-11-12 University Of New Mexico Treatment of aberrant cellular states with biomodulators
WO1992019240A1 (en) * 1991-05-01 1992-11-12 University Of New Mexico Treatment of aberrant cellular states with biomodulators
FR2687402B1 (fr) * 1992-02-14 1995-06-30 Lipha Nouveaux azaindoles, procedes de preparation et medicaments les contenant.
EP1535922A4 (en) 2002-07-11 2006-10-04 Takeda Pharmaceutical PYRROLOPYRIDINE DERIVATIVE AND ITS USE
TWI471133B (zh) 2004-03-30 2015-02-01 Vertex Pharma 適合作為ｊａｋ及其它蛋白質激酶抑制劑之氮雜吲哚
AU2007207533B8 (en) 2006-01-17 2012-06-28 Vertex Pharmaceuticals Incorporated Azaindoles useful as inhibitors of Janus kinases
KR20090091350A (ko) 2006-12-21 2009-08-27 버텍스 파마슈티칼스 인코포레이티드 단백질 키나제 억제제로 유용한 ５-시아노-４-피롤로[２,３ｂ]피리딘-３-일)-피리디민 유도체
TWI639596B (zh) 2009-06-17 2018-11-01 維泰克斯製藥公司 流感病毒複製之抑制劑
CA2822057A1 (en) 2010-12-16 2012-06-21 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
EP3578554A1 (en) 2013-11-13 2019-12-11 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
LT3421468T (lt) 2013-11-13 2021-01-11 Vertex Pharmaceuticals Incorporated Gripo virusų replikacijos inhibitorių paruošimo būdai
EP3294717B1 (en) 2015-05-13 2020-07-29 Vertex Pharmaceuticals Inc. Methods of preparing inhibitors of influenza viruses replication
MA42422A (fr) 2015-05-13 2018-05-23 Vertex Pharma Inhibiteurs de la réplication des virus de la grippe

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI61030C (fi) * 1976-02-19 1982-05-10 Sanofi Sa Foerfarande foer framstaellning av terapeutiskt verkande 2-substituerade-1- eller 3-benzoyl-indolizinderivat
JPS5559180A (en) * 1978-10-30 1980-05-02 Sankyo Co Ltd 4-hydroxy-2-pyrone ring compound, its preparation, and remedy for hyperlipemia comprising it as active constituent
US4474971A (en) * 1982-09-29 1984-10-02 Sandoz, Inc. (Tetrahydropyran-2-yl)-aldehydes
AU570021B2 (en) * 1982-11-22 1988-03-03 Novartis Ag Analogs of mevalolactone
EP0117228B1 (en) * 1983-01-24 1986-11-05 Sandoz Ag Analogs of mevalonolactone and derivatives thereof, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
US4571428A (en) * 1983-07-08 1986-02-18 Sandoz, Inc. 6-Substituted-4-hydroxy-tetrahydropyran-2-ones
AU573368B2 (en) * 1984-06-22 1988-06-02 Sandoz Ag Pyrazole analogs of mevalonolactone and derivatives thereof, process for their production and their use
US4677211A (en) * 1984-06-29 1987-06-30 Sandoz Pharmaceuticals Corp. Preparation of lactones
US4668794A (en) * 1985-05-22 1987-05-26 Sandoz Pharm. Corp. Intermediate imidazole acrolein analogs

Also Published As

Publication number Publication date
HU200769B (en) 1990-08-28
PT85662A (en) 1987-10-01
EP0265640A2 (en) 1988-05-04
KR880701719A (ko) 1988-11-04
PT85662B (pt) 1990-06-29
JPH01500834A (ja) 1989-03-23
HUT46914A (en) 1988-12-28
FI882160A (fi) 1988-05-09
FI882160A0 (fi) 1988-05-09
PL267646A1 (en) 1988-07-21
NZ221717A (en) 1990-08-28
EP0265640A3 (en) 1988-05-18
AU606621B2 (en) 1991-02-14
AU8022187A (en) 1988-04-07
DK254488D0 (da) 1988-05-09
WO1988001997A2 (en) 1988-03-24
DK254488A (da) 1988-06-24
WO1988001997A3 (en) 1988-04-07

Similar Documents

Publication Publication Date Title
IL81358A0 (en) Indolizine derivatives,their preparation and pharmaceutical and veterinary compositions containing them
IL84522A0 (en) Imidazopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL80296A (en) Phenylpyridone derivatives,their preparation and pharmaceutical compositions containing them
IL78581A0 (en) Imidazoquinoline derivatives,their preparation and pharmaceutical compositions containing them
ZA877530B (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same as well as processes for production thereof
IL87809A0 (en) Imidazopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL83821A0 (en) Azaindole and indolizine derivatives,their production and pharmaceutical compositions containing them
NZ225117A (en) Trans -2,2-dimethylchroman-3-ol derivatives and pharmaceutical compositions
IL83659A0 (en) Xanthine derivatives,their production and pharmaceutical compositions containing them
IL83432A (en) N-phenylcarboxamide derivatives,their preparation and pharmaceutical compositions containing them
HUT41771A (en) Process for producing benzimidazol derivatives, imidazo/4,5-b/pyridine derivatives and pharmaceutical compositions containing them
IL80339A0 (en) Benzimidazole derivatives,their preparation and pharmaceutical compositions containing them
IL74244A0 (en) Quinoline and naphthyridine derivatives,their preparation and pharmaceutical compositions containing them
IL79402A0 (en) Poly-4-aminopyrrole-2-carboxamido derivatives,their preparation and pharmaceutical compositions containing them
IL86639A0 (en) Trycyclic pyridone derivatives,their manufacture and pharmaceutical compositions containing them
IL83049A0 (en) 4-pyridone derivatives,their manufacture and pharmaceutical compositions containing them
IL84128A0 (en) 3-propenylcephem derivatives,their preparation and pharmaceutical compositions containing them
NZ224032A (en) Imidazo(1,2-a)pyridine derivatives and pharmaceutical compositions
NZ219971A (en) Tetrahydropyrido (2,3-d pyrimidine derivatives and pharmaceutical compositions
IL80658A0 (en) 6,7,8,9-tetrahydro-10-methyl-pyrido(1,2-a)indol-9-amines and derivatives thereof,their preparation and pharmaceutical compositions containing them
IL84728A (en) Bicyclic v-triazine-4-one derivatives,their manufacture and pharmaceutical compositions containing them
IL83753A (en) Sulphonamidoethyl derivatives,their preparation and pharmaceutical compositions containing them
IL79934A0 (en) Xanthine derivatives,their production and pharmaceutical compositions containing them
ZA855937B (en) Imidazo 1,2-a quinoline derivatives,their preparation and pharmaceutical compositions containing them
NZ222080A (en) Imidazo(4,5-b)pyridin-2-one derivatives and pharmaceutical compositions